Video Experimental Relacionado
Updated: Sep 9, 2025
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.6K
Modulación de la neuroinflamación como estrategia terapéutica para el control de la epilepsia
Alberto Javier Ramos1, Alberto Lazarowski2, Angélica Vega-García3
1Laboratory of Molecular Neuropathology. IBCN University of Buenos Aires-CONICET, School of Medicine, University of Buenos Aires, Argentina.
Seizure
|August 28, 2025
Resumen
La neuroinflamación conduce al desarrollo de la epilepsia y las convulsiones. Dirigirse a las vías inflamatorias ofrece nuevas estrategias terapéuticas y biomarcadores para enfermedades como la enfermedad de Alzheimer.
Área de la Ciencia:
- La neurociencia
- Inmunología
- Neurología
Sus antecedentes:
- La neuroinflamación es parte integral de la patogénesis de la epilepsia.
- Los astrocitos y la microglía median la inflamación crónica, contribuyendo a la epileptogénesis.
- La liberación de histamina por los mastocitos y la neurotransmisión histaminérgica cerebral representan un mecanismo de aprehensión poco estudiado.
Objetivo del estudio:
- Revisar las múltiples funciones de la neuroinflamación en la epilepsia.
- Explorar los vínculos entre la epilepsia y la enfermedad de Alzheimer a través de vías inflamatorias compartidas.
- Para discutir nuevas estrategias terapéuticas dirigidas a la neuroinflamación para el control de las convulsiones.
Principales métodos:
- Examen crítico de la literatura existente sobre la neuroinflamación y la epilepsia.
- Análisis de las funciones de las células gliales, los mastocitos y la histamina en las convulsiones.
- Investigación de los mediadores inflamatorios como biomarcadores pronósticos.
- Revisión de los mecanismos inflamatorios compartidos entre la epilepsia y la enfermedad de Alzheimer.
Principales resultados:
- Los astrocitos y la microglía tienen un doble papel en la inflamación crónica y la epileptogénesis.
- Las interacciones entre la histamina y los mastocitos representan un nuevo mecanismo en las convulsiones.
- Los mediadores inflamatorios muestran potencial como biomarcadores para el pronóstico y el riesgo.
- Las vías inflamatorias compartidas, incluidos los astrocitos reactivos y la ferroptosis, vinculan la epilepsia y la enfermedad de Alzheimer.
Conclusiones:
- La neuroinflamación es un factor crítico en el inicio, la progresión y la epileptogénesis de la epilepsia.
- La modulación de la neuroinflamación presenta vías terapéuticas prometedoras para el manejo de las convulsiones.
- Comprender las vías inflamatorias compartidas puede ayudar a identificar a las personas en riesgo de epilepsia y enfermedad de Alzheimer.
Palabras clave:
Tratamiento antiepilépticoLos biomarcadoresComorbilidadesLa epilepsiaLa neuroinflamaciónMás Videos Relacionados
Videos de Conceptos Relacionados
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
01:24Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
01:14Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
01:17Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608
01:08Antiepileptic Drugs: Sodium Channel Blockers
869
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
869